Cite
HARVARD Citation
Buhl, R. et al. (n.d.). P254 Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat® Improves Outcomes Versus Mono-components In Copd In Two 1-year Studies. Thorax. pp. A188-A189. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Buhl, R. et al. (n.d.). P254 Once-daily Tiotropium And Olodaterol Fixed-dose Combination Via The Respimat® Improves Outcomes Versus Mono-components In Copd In Two 1-year Studies. Thorax. pp. A188-A189. [Online].